{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:21:39Z","timestamp":1792095699643,"version":"4.4.0"},"reference-count":238,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_197655"],"award-info":[{"award-number":["310030_197655"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["4078P0_198297"],"award-info":[{"award-number":["4078P0_198297"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII5_193694"],"award-info":[{"award-number":["CRSII5_193694"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","award":["FF20099"],"award-info":[{"award-number":["FF20099"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Atherosclerotic vascular disease remains the most common cause of ischemia, myocardial infarction, and stroke. Vascular function is determined by structural and functional properties of the arterial vessel wall, which consists of three layers, namely the adventitia, media, and intima. Key cells in shaping the vascular wall architecture and warranting proper vessel function are vascular smooth muscle cells in the arterial media and endothelial cells lining the intima. Pathological alterations of this vessel wall architecture called vascular remodeling can lead to insufficient vascular function and subsequent ischemia and organ damage. One major pathomechanism driving this detrimental vascular remodeling is atherosclerosis, which is initiated by endothelial dysfunction allowing the accumulation of intimal lipids and leukocytes. Inflammatory mediators such as cytokines, chemokines, and modified lipids further drive vascular remodeling ultimately leading to thrombus formation and\/or vessel occlusion which can cause major cardiovascular events. Although it is clear that vascular wall remodeling is an elementary mechanism of atherosclerotic vascular disease, the diverse underlying pathomechanisms and its consequences are still insufficiently understood.<\/jats:p>","DOI":"10.3389\/fcvm.2022.868934","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:41:02Z","timestamp":1651624862000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Inflammatory Mediators in Atherosclerotic Vascular Remodeling"],"prefix":"10.3389","volume":"9","author":[{"given":"Bryce R.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Yerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel P. C.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Maike","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schindewolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gistera","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fgene.2012.00290","article-title":"Mechanisms of arterial remodeling: lessons from genetic diseases","volume":"3","author":"Van Varik","year":"2012","journal-title":"Front Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e58054","DOI":"10.1371\/journal.pone.0058054","article-title":"Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation","volume":"8","author":"Barthwal","year":"2013","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cvr\/cvv147","article-title":"Monocyte trafficking across the vessel wall","volume":"107","author":"Gerhardt","year":"2015","journal-title":"Cardiovasc Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jvs.2013.07.097","article-title":"Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin","volume":"60","author":"Airhart","year":"2014","journal-title":"J Vasc Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.yexcr.2011.01.005","article-title":"Chemokines in health and disease","volume":"317","author":"Raman","year":"2011","journal-title":"Exp Cell Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-0038-1676988","article-title":"Atypical chemokine receptors in cardiovascular disease","volume":"119","author":"Gencer","year":"2019","journal-title":"Thromb Haemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.dci.2003.09.006","article-title":"Chemokines","volume":"28","author":"Laing","year":"2004","journal-title":"Dev Comp Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jacc.2010.04.066","article-title":"A new monocyte chemotactic protein-1\/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia\/reperfusion injury in mice","volume":"56","author":"Liehn","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41598-017-00104-z","article-title":"A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy","volume":"7","author":"Bot","year":"2017","journal-title":"Sci Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.cmet.2018.05.002","article-title":"Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis","volume":"28","author":"Winter","year":"2018","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1111\/j.1476-5381.2012.01866.x","article-title":"Key role of PI3Kgamma in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration","volume":"166","author":"Fougerat","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.ATV.0000019009.73586.7F","article-title":"Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1","volume":"22","author":"Viedt","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yjmcc.2021.03.010","article-title":"Role of myeloid-derived chemokine CCL5\/RANTES at an early stage of atherosclerosis","volume":"156","author":"Jongstra-Bilen","year":"2021","journal-title":"J Mol Cell Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1159\/000490024","article-title":"The CCL5\/CCR5 Axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching","volume":"47","author":"Lin","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1159\/000430224","article-title":"Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction","volume":"37","author":"Jiang","year":"2015","journal-title":"Cell Physiol Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurheartj\/ehq107","article-title":"SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis","volume":"31","author":"Stein","year":"2010","journal-title":"Eur Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/cvr\/cvu036","article-title":"Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells","volume":"102","author":"Halvorsen","year":"2014","journal-title":"Cardiovasc Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/ATVBAHA.107.147827","article-title":"CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice","volume":"28","author":"Van Wanrooij","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/cvr\/cvz122","article-title":"Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kgamma-dependent T cells response","volume":"116","author":"Lupieri","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1194\/jlr.RA119000100","article-title":"CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4\/GSK3\u03b2\/\u03b2-catenin(T120)\/TCF21 pathway","volume":"60","author":"Gao","year":"2019","journal-title":"J Lipid Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/01.CIR.0000099508.76665.9A","article-title":"Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice","volume":"108","author":"Schober","year":"2003","journal-title":"Circulation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/CIRCRESAHA.109.212647","article-title":"Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation","volume":"107","author":"Subramanian","year":"2010","journal-title":"Circ Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/ATVBAHA.112.301162","article-title":"CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice","volume":"33","author":"Akhtar","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.112.276444","article-title":"The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase\/Akt signaling","volume":"111","author":"Borst","year":"2012","journal-title":"Circ Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/hq1001.096652","article-title":"Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions","volume":"21","author":"Minami","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bbrc.2004.10.160","article-title":"The chemokine and scavenger receptor CXCL16\/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma","volume":"325","author":"Wagsater","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.RES.0000121105.72718.5C","article-title":"Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines","volume":"94","author":"Zeiffer","year":"2004","journal-title":"Circ Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molmet.2018.11.011","article-title":"CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice","volume":"20","author":"Riopel","year":"2019","journal-title":"Mol Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1161\/01.ATV.0000234947.47788.8c","article-title":"CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury","volume":"26","author":"Liu","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1096\/fj.09-132225","article-title":"Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction","volume":"24","author":"Kumar","year":"2010","journal-title":"FASEB J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/1357-4310(96)88772-7","article-title":"Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease","volume":"2","author":"Rollins","year":"1996","journal-title":"Mol Med Today."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1161\/ATVBAHA.117.310082","article-title":"PAR2 (protease-activated receptor 2) deficiency attenuates atherosclerosis in mice","volume":"38","author":"Jones","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00041433-199810000-00003","article-title":"Chemokines and atherosclerosis","volume":"9","author":"Terkeltaub","year":"1998","journal-title":"Curr Opin Lipidol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/01.RES.70.2.314","article-title":"JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells","volume":"70","author":"Taubman","year":"1992","journal-title":"Circ Res."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4049\/jimmunol.153.5.2052","article-title":"NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene","volume":"153","author":"Ueda","year":"1994","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1073\/pnas.88.12.5252","article-title":"Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions","volume":"88","author":"Yla-Herttuala","year":"1991","journal-title":"Proc Natl Acad Sci USA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/jmcc.1996.0285","article-title":"Plasma levels of the monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction","volume":"29","author":"Matsumori","year":"1997","journal-title":"J Mol Cell Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/ATVBAHA.121.316091","article-title":"Monocyte-chemoattractant protein-1 levels in human atherosclerotic lesions associate with plaque vulnerability","volume":"41","author":"Georgakis","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"110624","DOI":"10.1016\/j.exger.2019.05.013","article-title":"Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women","volume":"124","author":"Basurto","year":"2019","journal-title":"Exp Gerontol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/CIRCULATIONAHA.107.720466","article-title":"Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes","volume":"117","author":"Fougerat","year":"2008","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/01.RES.0000109793.17591.4E","article-title":"Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice","volume":"94","author":"Veillard","year":"2004","journal-title":"Circ Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"10647","DOI":"10.1038\/s41598-018-29026-0","article-title":"Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis","volume":"8","author":"Vajen","year":"2018","journal-title":"Sci Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","article-title":"Targeting CCL5 in inflammation","volume":"17","author":"Marques","year":"2013","journal-title":"Expert Opin Ther Targets."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/01.CIR.103.13.1772","article-title":"RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium","volume":"103","author":"Von Hundelshausen","year":"2001","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1161\/01.CIR.0000028590.02477.6F","article-title":"Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury","volume":"106","author":"Schober","year":"2002","journal-title":"Circulation."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"9466","DOI":"10.1038\/s41598-018-27710-9","article-title":"CXCL4\/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration","volume":"8","author":"Fox","year":"2018","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb Haemost."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1160\/TH07-04-0271","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE\u2212\/\u2212 mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb Haemost."},{"key":"B55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yjmcc.2019.03.017","article-title":"CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment","volume":"130","author":"Blin","year":"2019","journal-title":"J Mol Cell Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1","volume":"391","author":"Gunn","year":"1998","journal-title":"Nature."},{"key":"B57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","article-title":"Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization","volume":"27","author":"Damas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fcell.2019.00212","article-title":"CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention","volume":"7","author":"Yan","year":"2019","journal-title":"Front Cell Dev Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12192-013-0417-z","article-title":"Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36","volume":"18","author":"Zhou","year":"2013","journal-title":"Cell Stress Chaperones."},{"key":"B60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1475-2840-8-50","article-title":"MMP-1 serum levels predict coronary atherosclerosis in humans","volume":"8","author":"Lehrke","year":"2009","journal-title":"Cardiovasc Diabetol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2147\/DDDT.S72394","article-title":"CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions","volume":"8","author":"Akhavanpoor","year":"2014","journal-title":"Drug Des Devel Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J Clin Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"936109","DOI":"10.4061\/2011\/936109","article-title":"Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans","volume":"2011","author":"Segers","year":"2011","journal-title":"Int J Inflam."},{"key":"B65","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1536\/ihj.14-300","article-title":"Elevated concentration of interferon-inducible protein of 10 kD (IP-10) is associated with coronary atherosclerosis","volume":"56","author":"Niki","year":"2015","journal-title":"Int Heart J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/ATVBAHA.112.300354","article-title":"Trophoblast-induced changes in C-x-C motif chemokine 10 expression contribute to vascular smooth muscle cell dedifferentiation during spiral artery remodeling","volume":"33","author":"Wallace","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.RES.86.2.131","article-title":"The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques","volume":"86","author":"Abi-Younes","year":"2000","journal-title":"Circ Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.118.037953","article-title":"CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease","volume":"139","author":"Doring","year":"2019","journal-title":"Circulation."},{"key":"B70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2018.04.067","article-title":"Blood CSF1 and CXCL12 as causal mediators of coronary artery disease","volume":"72","author":"Sjaarda","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"BSR20193267","DOI":"10.1042\/BSR20193267","article-title":"Foam cells promote atherosclerosis progression by releasing CXCL12","volume":"40","author":"Li","year":"2020","journal-title":"Biosci Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1161\/CIRCULATIONAHA.107.694992","article-title":"Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction","volume":"117","author":"Saxena","year":"2008","journal-title":"Circulation."},{"key":"B73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2018.01.032","article-title":"Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction","volume":"270","author":"Maracle","year":"2018","journal-title":"Atherosclerosis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile 'special agents' in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb Haemost."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073490","article-title":"The role of CXCL16 in the pathogenesis of cancer and other diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1160\/TH14-11-0911","article-title":"Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall","volume":"114","author":"Meyer Dos Santos","year":"2015","journal-title":"Thromb Haemost."},{"key":"B78","doi-asserted-by":"publisher","first-page":"110141","DOI":"10.1016\/j.cellsig.2021.110141","article-title":"Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia\/reperfusion injury by transcriptional activation of CXCL16","volume":"87","author":"Zhao","year":"2021","journal-title":"Cell Signal."},{"key":"B79","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.107.743872","article-title":"Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2\u2212\/\u2212 mice: evidence for independent chemokine functions in atherogenesis","volume":"117","author":"Saederup","year":"2008","journal-title":"Circulation."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20022156","article-title":"Fractalkine preferentially mediates arrest and migration of CD16+ monocytes","volume":"197","author":"Ancuta","year":"2003","journal-title":"J Exp Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"964","DOI":"10.7150\/ijms.49460","article-title":"STAT3\/miR-15a-5p\/CX3CL1 Loop Regulates Proliferation and Migration of Vascular Endothelial Cells in Atherosclerosis","volume":"18","author":"Li","year":"2021","journal-title":"Int J Med Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/cvr\/cvaa234","article-title":"Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction","volume":"117","author":"Roy-Chowdhury","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0195657","DOI":"10.1371\/journal.pone.0195657","article-title":"DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice","volume":"13","author":"Zhou","year":"2018","journal-title":"PLoS One."},{"key":"B85","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"589654","DOI":"10.3389\/fimmu.2020.589654","article-title":"Targeting IL-1beta in the treatment of atherosclerosis","volume":"11","author":"Mai","year":"2020","journal-title":"Front Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1161\/ATVBAHA.113.303145","article-title":"Cross talk between vascular smooth muscle cells and monocytes through interleukin- 1beta\/interleukin-18 signaling promotes vein graft thickening","volume":"34","author":"Li","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B88","first-page":"394","article-title":"Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion","volume":"121","author":"Bevilacqua","year":"1985","journal-title":"Am J Pathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"106996","DOI":"10.1016\/j.intimp.2020.106996","article-title":"The dipeptidyl peptidase (DPP)-4 inhibitor trelagliptin inhibits IL-1beta-induced endothelial inflammation and monocytes attachment","volume":"89","author":"Meng","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fphys.2015.00365","article-title":"Endothelial barrier and its abnormalities in cardiovascular disease","volume":"6","author":"Chistiakov","year":"2015","journal-title":"Front Physiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1172\/JCI113346","article-title":"Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids","volume":"81","author":"Libby","year":"1988","journal-title":"J Clin Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1172\/JCI114498","article-title":"Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6","volume":"85","author":"Loppnow","year":"1990","journal-title":"J Clin Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3390\/ijms18122563","article-title":"Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature","volume":"18","author":"Didion","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"118304","DOI":"10.1016\/j.lfs.2020.118304","article-title":"Raloxifene inhibits IL-6\/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE(\u2212\/\u2212) mice","volume":"261","author":"Luo","year":"2020","journal-title":"Life Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1471-4906(02)00013-3","article-title":"IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation","volume":"24","author":"Kaplanski","year":"2003","journal-title":"Trends Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.atherosclerosis.2007.02.023","article-title":"Atheroprotective role of interleukin-6 in diet- and\/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model","volume":"197","author":"Madan","year":"2008","journal-title":"Atherosclerosis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e000476","DOI":"10.1161\/JAHA.113.000476","article-title":"IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR\/mgR mouse model of severe Marfan syndrome","volume":"3","author":"Ju","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B99","doi-asserted-by":"publisher","first-page":"H1382","DOI":"10.1152\/ajpheart.00712.2014","article-title":"Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice","volume":"308","author":"Du","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1096\/fj.09-148155","article-title":"Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice","volume":"24","author":"Han","year":"2010","journal-title":"FASEB J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1160\/TH14-06-0509","article-title":"Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function","volume":"113","author":"Han","year":"2015","journal-title":"Thromb Haemost."},{"key":"B102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","article-title":"IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation","volume":"112","author":"Jung","year":"2017","journal-title":"Basic Res Cardiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4049\/jimmunol.1700901","article-title":"Mesenchymal stromal cells stimulate the proliferation and IL-22 production of group 3 innate lymphoid cells","volume":"201","author":"Van Hoeven","year":"2018","journal-title":"J Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2011.10.093","article-title":"Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque","volume":"154","author":"Xia","year":"2012","journal-title":"Int J Cardiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10020-021-00353-9","article-title":"Interleukin-22: a potential therapeutic target in atherosclerosis","volume":"27","author":"Luo","year":"2021","journal-title":"Mol Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2015.08.006","article-title":"IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice","volume":"242","author":"Rattik","year":"2015","journal-title":"Atherosclerosis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1111\/jcmm.14967","article-title":"IL-22 produced by Th22 cells aggravates atherosclerosis development in ApoE(\u2212\/\u2212) mice by enhancing DC-induced Th17 cell proliferation","volume":"24","author":"Shi","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/ATVBAHA.111.231431","article-title":"Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques","volume":"31","author":"Demyanets","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood.V76.5.965.965","article-title":"Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells","volume":"76","author":"Carlos","year":"1990","journal-title":"Blood."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice","volume":"24","author":"Branen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4161\/cc.11.1.18473","article-title":"TNF-alpha-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes","volume":"11","author":"Davis","year":"2012","journal-title":"Cell Cycle."},{"key":"B114","doi-asserted-by":"publisher","first-page":"H552","DOI":"10.1152\/ajpheart.00936.2013","article-title":"Tongxinluo inhibits vascular inflammation and neointimal hyperplasia through blockade of the positive feedback loop between miR-155 and TNF-alpha","volume":"307","author":"Zhang","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B115","first-page":"123","article-title":"Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation","volume":"60","author":"Zapolska-Downar","year":"2009","journal-title":"J Physiol Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"174216","DOI":"10.1016\/j.ejphar.2021.174216","article-title":"Regulatory effects of IL-1beta in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1","volume":"905","author":"Shen","year":"2021","journal-title":"Eur J Pharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1182\/blood-2006-08-040097","article-title":"Mechanisms of induction of endothelial cell E-selectin expression by smooth muscle cells and its inhibition by shear stress","volume":"110","author":"Chiu","year":"2007","journal-title":"Blood."},{"key":"B118","doi-asserted-by":"publisher","first-page":"599415","DOI":"10.3389\/fimmu.2020.599415","article-title":"Role of vascular smooth muscle cell plasticity and interactions in vessel wall inflammation","volume":"11","author":"Sorokin","year":"2020","journal-title":"Front Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000484623","article-title":"Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction","volume":"44","author":"Boini","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"731273","DOI":"10.3389\/fendo.2021.731273","article-title":"Roles and mechanisms of dipeptidyl peptidase 4 inhibitors in vascular aging","volume":"12","author":"Cao","year":"2021","journal-title":"Front Endocrinol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","article-title":"Interleukin-1beta has atheroprotective effects in advanced atherosclerotic lesions of mice","volume":"24","author":"Gomez","year":"2018","journal-title":"Nat Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e005038","DOI":"10.1161\/JAHA.116.005038","article-title":"Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study","volume":"6","author":"Bacchiega","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B124","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial","volume":"78","author":"Guttman-Yassky","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/medicina56090473","article-title":"Methotrexate and adalimumab decrease the serum levels of cardiovascular disease biomarkers (VCAM-1 and E-Selectin) in plaque psoriasis","volume":"56","author":"Zdanowska","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e14110","DOI":"10.1111\/dth.14110","article-title":"Long-term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study","volume":"33","author":"Gkalpakiotis","year":"2020","journal-title":"Dermatol Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10067-014-2718-8","article-title":"Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis","volume":"34","author":"Vassilopoulos","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10067-017-3657-y","article-title":"The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis","volume":"37","author":"Vlachopoulos","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21542\/gcsp.2018.2","article-title":"CANTOS: A breakthrough that proves the inflammatory hypothesis of atherosclerosis","volume":"2018","author":"Hassan","year":"2018","journal-title":"Glob Cardiol Sci Pract."},{"key":"B132","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1161\/01.CIR.0000142085.39015.31","article-title":"Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and\/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications","volume":"110","author":"Chi","year":"2004","journal-title":"Circulation."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/01.ATV.0000127025.48140.a3","article-title":"Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice","volume":"24","author":"Isoda","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J Clin Invest."},{"key":"B136","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.MP.0000067685.57858.D7","article-title":"Morphology of the internal elastic lamina in arteries from pulmonary hypertensive patients: a confocal laser microscopy study","volume":"16","author":"Aiello","year":"2003","journal-title":"Mod Pathol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Merhi-Soussi","year":"2005","journal-title":"Cardiovasc Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1194\/jlr.M054015","article-title":"A brief elevation of serum amyloid A is sufficient to increase atherosclerosis","volume":"56","author":"Thompson","year":"2015","journal-title":"J Lipid Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fimmu.2019.01093","article-title":"Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines","volume":"10","author":"West","year":"2019","journal-title":"Front Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/FJC.0000000000000567","article-title":"Simvastatin modulates interaction between vascular smooth muscle cell\/macrophage and TNF-alpha-activated endothelial cell","volume":"71","author":"Chu","year":"2018","journal-title":"J Cardiovasc Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"106806","DOI":"10.1016\/j.vph.2020.106806","article-title":"Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome","volume":"135","author":"Gager","year":"2020","journal-title":"Vascul Pharmacol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"6657734","DOI":"10.1155\/2020\/6657734","article-title":"The role of miRNA-146a and proinflammatory cytokines in carotid atherosclerosis","volume":"2020","author":"Huang","year":"2020","journal-title":"Biomed Res Int."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/ijms17091394","article-title":"TLR4-activated MAPK-IL-6 axis regulates vascular smooth muscle cell function","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12291-016-0576-7","article-title":"Lysyl oxidase: its diversity in health and diseases","volume":"32","author":"Kumari","year":"2017","journal-title":"Indian J Clin Biochem."},{"key":"B146","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation."},{"key":"B147","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.08933","article-title":"Mechanisms and Subclinical Consequences of Aortic Stiffness","volume":"70","author":"Pierce","year":"2017","journal-title":"Hypertension."},{"key":"B148","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","article-title":"A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis","volume":"219","author":"Protogerou","year":"2011","journal-title":"Atherosclerosis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-800267-4.00005-5","article-title":"Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans","volume":"122","author":"Shouval","year":"2014","journal-title":"Adv Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"H866","DOI":"10.1152\/ajpheart.00918.2003","article-title":"IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo","volume":"287","author":"Mazighi","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2006.09.032","article-title":"The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice","volume":"193","author":"Eefting","year":"2007","journal-title":"Atherosclerosis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2003.08.032","article-title":"Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice","volume":"172","author":"Namiki","year":"2004","journal-title":"Atherosclerosis."},{"key":"B155","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jss.2004.03.025","article-title":"Interleukin-10 attenuates the response to vascular injury","volume":"121","author":"Zimmerman","year":"2004","journal-title":"J Surg Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1161\/01.ATV.19.12.2823","article-title":"IL-10: an \u201cimmunologic scalpel\u201d for atherosclerosis?","volume":"19","author":"Terkeltaub","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"9988","DOI":"10.7150\/thno.64229","article-title":"Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment","volume":"11","author":"Bu","year":"2021","journal-title":"Theranostics."},{"key":"B158","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.immuni.2018.09.011","article-title":"An interleukin-23-interleukin-22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis","volume":"49","author":"Fatkhullina","year":"2018","journal-title":"Immunity"},{"key":"B159","doi-asserted-by":"publisher","first-page":"106277","DOI":"10.1016\/j.intimp.2020.106277","article-title":"Effects of IL-22 on cardiovascular diseases","volume":"81","author":"Che","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"107475","DOI":"10.1016\/j.intimp.2021.107475","article-title":"The role of interleukin-10 family members in cardiovascular diseases","volume":"94","author":"Xu","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1194\/jlr.M044305","article-title":"IL-22 is induced by S100\/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1","volume":"55","author":"Chellan","year":"2014","journal-title":"J Lipid Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","article-title":"IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis","volume":"9","author":"Hou","year":"2018","journal-title":"Protein Cell."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e71466","DOI":"10.1371\/journal.pone.0071466","article-title":"Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17\/Th1 cell in patients with acute coronary syndrome","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.3389\/fimmu.2018.02226","article-title":"The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis","volume":"9","author":"Kragstrup","year":"2018","journal-title":"Front Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2018.05.056","article-title":"The IL-33\/ST2 pathway, inflammation and atherosclerosis: trigger and target?","volume":"267","author":"Aimo","year":"2018","journal-title":"Int J Cardiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cyto.2019.05.010","article-title":"IL-33\/IL-33R in various types of carotid artery atherosclerotic lesions","volume":"120","author":"Stankovic","year":"2019","journal-title":"Cytokine."},{"key":"B167","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2015.01.008","article-title":"The role of IL-33\/ST2L signals in the immune cells","volume":"164","author":"Lu","year":"2015","journal-title":"Immunol Lett."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/cvr\/cvy166","article-title":"Conflicting vascular and metabolic impact of the IL-33\/sST2 axis","volume":"114","author":"Altara","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"e79176","DOI":"10.1371\/journal.pone.0079176","article-title":"A role for soluble ST2 in vascular remodeling associated with obesity in rats","volume":"8","author":"Martinez-Martinez","year":"2013","journal-title":"PLoS One."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e0143153","DOI":"10.1371\/journal.pone.0143153","article-title":"Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients","volume":"10","author":"Lopez-Mejias","year":"2015","journal-title":"PLoS ONE."},{"key":"B171","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/iid3.62","article-title":"Atherosclerosis severity is not affected by a deficiency in IL-33\/ST2 signaling","volume":"3","author":"Martin","year":"2015","journal-title":"Immun Inflamm Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1755-5922.2010.00159.x","article-title":"Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis","volume":"29","author":"Full","year":"2011","journal-title":"Cardiovasc Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/01.ATV.0000261548.49790.63","article-title":"Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis","volume":"27","author":"Zhang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e6113","DOI":"10.1371\/journal.pone.0006113","article-title":"Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice","volume":"4","author":"Xanthoulea","year":"2009","journal-title":"PLoS ONE."},{"key":"B175","doi-asserted-by":"publisher","first-page":"e21391","DOI":"10.1096\/fj.202000764R","article-title":"A strategy to prevent atherosclerosis via TNF receptor regulation","volume":"35","author":"Kim","year":"2021","journal-title":"FASEB J."},{"key":"B176","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000163407","article-title":"Characterization and expression kinetics of an endothelial cell activation antigen present in vivo only in acute inflammatory tissues","volume":"55","author":"Goerdt","year":"1987","journal-title":"Exp Cell Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.169.6.1977","article-title":"Tumor necrosis factor\/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins","volume":"169","author":"Brett","year":"1989","journal-title":"J Exp Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur Heart J."},{"key":"B179","doi-asserted-by":"publisher","first-page":"7157865","DOI":"10.1155\/2019\/7157865","article-title":"Adipokine chemerin stimulates progression of atherosclerosis in ApoE(\u2013\/\u2013) mice","volume":"2019","author":"Liu","year":"2019","journal-title":"Biomed Res Int."},{"key":"B180","doi-asserted-by":"publisher","first-page":"e0165305","DOI":"10.1371\/journal.pone.0165305","article-title":"Chemerin stimulates vascular smooth muscle cell proliferation and carotid neointimal hyperplasia by activating mitogen-activated protein kinase signaling","volume":"11","author":"Xiong","year":"2016","journal-title":"PLoS ONE."},{"key":"B181","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1007\/s11033-020-05767-y","article-title":"The EphA2 and cancer connection: potential for immune-based interventions","volume":"47","author":"London","year":"2020","journal-title":"Mol Biol Rep."},{"key":"B182","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.026644","article-title":"EphA2 expression regulates inflammation and fibroproliferative remodeling in atherosclerosis","volume":"136","author":"Finney","year":"2017","journal-title":"Circulation."},{"key":"B183","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12964-020-00692-w","article-title":"S-1-propenylcysteine improves TNF-alpha-induced vascular endothelial barrier dysfunction by suppressing the GEF-H1\/RhoA\/Rac pathway","volume":"19","author":"Kunimura","year":"2021","journal-title":"Cell Commun Signal."},{"key":"B184","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.08.030","article-title":"Anti-tumor necrosis factor-alpha therapy increases plaque burden in a mouse model of experimental atherosclerosis","volume":"277","author":"Oberoi","year":"2018","journal-title":"Atherosclerosis."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/ATVBAHA.116.307736","article-title":"Loss of macrophage low-density lipoprotein receptor-related protein 1 confers resistance to the antiatherogenic effects of tumor necrosis factor-alpha inhibition","volume":"36","author":"Zhu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B186","first-page":"625","article-title":"Tumor necrosis factor-alpha-induced cyclooxygenase-2 overexpression in eutopic endometrium of women with endometriosis by stromal cell culture through nuclear factor-kappaB activation","volume":"54","author":"Kim","year":"2009","journal-title":"J Reprod Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00403-016-1712-1","article-title":"Psoriasis and cardiovascular events: updating the evidence","volume":"309","author":"Raaby","year":"2017","journal-title":"Arch Dermatol Res."},{"key":"B188","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/jhh.2011.59","article-title":"The association between aortic augmentation index and cardiovascular risk factors in a large unselected population","volume":"26","author":"Janner","year":"2012","journal-title":"J Hum Hypertens."},{"key":"B189","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","article-title":"Effects of anti-TNF-alpha treatment on lipid profile in rheumatic diseases: an analytical cohort study","volume":"18","author":"Hassan","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B190","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.3390\/ijms22168889","article-title":"GDF15 and cardiac cells: current concepts and new insights","volume":"22","author":"Rochette","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"929536","DOI":"10.1155\/2014\/929536","article-title":"Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome","volume":"2014","author":"Dominguez-Rodriguez","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B194","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijcard.2017.03.101","article-title":"Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis","volume":"241","author":"Gohar","year":"2017","journal-title":"Int J Cardiol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1681\/ASN.2016080919","article-title":"Growth differentiation factor-15 and risk of CKD progression","volume":"28","author":"Nair","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"618","DOI":"10.11909\/j.issn.1671-5411.2018.10.002","article-title":"Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failure","volume":"15","author":"Liu","year":"2018","journal-title":"J Geriatr Cardiol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.hlc.2019.03.004","article-title":"Analysis of novel cardiovascular biomarkers in patients with pulmonary hypertension (PH)","volume":"29","author":"Mirna","year":"2020","journal-title":"Heart Lung Circ."},{"key":"B198","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.1074\/jbc.M113.516278","article-title":"Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation","volume":"289","author":"Xu","year":"2014","journal-title":"J Biol Chem."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/ehf2.12728","article-title":"Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player","volume":"7","author":"Wesseling","year":"2020","journal-title":"ESC Heart Fail."},{"key":"B200","doi-asserted-by":"publisher","first-page":"H709","DOI":"10.1152\/ajpheart.00543.2012","article-title":"Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium","volume":"304","author":"Mazagova","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jcp.22102","article-title":"Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes","volume":"224","author":"Heger","year":"2010","journal-title":"J Cell Physiol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","article-title":"GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation","volume":"98","author":"Xu","year":"2006","journal-title":"Circ Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"De Jager","year":"2011","journal-title":"J Exp Med."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","article-title":"Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support","volume":"14","author":"Lok","year":"2012","journal-title":"Eur J Heart Fail."},{"key":"B205","doi-asserted-by":"publisher","first-page":"88","DOI":"10.11909\/j.issn.1671-5411.2016.01.002","article-title":"Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure","volume":"13","author":"Wang","year":"2016","journal-title":"J Geriatr Cardiol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"e012826","DOI":"10.1161\/JAHA.119.012826","article-title":"Roles of growth differentiation factor 15 in atherosclerosis and coronary artery disease","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"B207","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.plefa.2011.04.020","article-title":"Lipid body function in eicosanoid synthesis: an update","volume":"85","author":"Bozza","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B209","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2353\/ajpath.2009.080012","article-title":"Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha","volume":"174","author":"Itatsu","year":"2009","journal-title":"Am J Pathol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.prostaglandins.2012.07.001","article-title":"Tumor necrosis factor-alpha induces renal cyclooxygenase-2 expression in response to hypercalcemia","volume":"99","author":"Battula","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B211","first-page":"710","article-title":"Prostaglandin E2 contracts vascular smooth muscle and inhibits potassium currents in vascular smooth muscle cells of rat tail artery","volume":"275","author":"Ren","year":"1995","journal-title":"J Pharmacol Exp Ther."},{"key":"B212","doi-asserted-by":"publisher","first-page":"22175","DOI":"10.1074\/jbc.M302769200","article-title":"Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells","volume":"278","author":"Ragolia","year":"2003","journal-title":"J Biol Chem."},{"key":"B213","doi-asserted-by":"publisher","first-page":"14496","DOI":"10.1021\/bi00252a016","article-title":"Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals","volume":"33","author":"An","year":"1994","journal-title":"Biochemistry."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.08.009","article-title":"Prostaglandin E2 receptor subtypes in human blood and vascular cells","volume":"695","author":"Foudi","year":"2012","journal-title":"Eur J Pharmacol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1083\/jcb.145.4.727","article-title":"Changes in the balance of phosphoinositide 3-kinase\/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK\/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells","volume":"145","author":"Hayashi","year":"1999","journal-title":"J Cell Biol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"C886","DOI":"10.1152\/ajpcell.00449.2006","article-title":"Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters","volume":"292","author":"Yoshida","year":"2007","journal-title":"Am J Physiol Cell Physiol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.1073\/pnas.0606586103","article-title":"Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med."},{"key":"B219","doi-asserted-by":"publisher","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"Mcgettigan","year":"2011","journal-title":"PLoS Med."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/01.ATV.0000092941.77774.3C","article-title":"Mechanisms of leukotriene B4\u2013triggered monocyte adhesion","volume":"23","author":"Friedrich","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"J Clin Invest."},{"key":"B222","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/07853890600982737","article-title":"Leukotriene receptors in atherosclerosis","volume":"38","author":"Back","year":"2006","journal-title":"Ann Med."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2432958","DOI":"10.1155\/2017\/2432958","article-title":"Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases","volume":"2017","author":"Colazzo","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1073\/pnas.242716099","article-title":"Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis","volume":"100","author":"Spanbroek","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B225","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1073\/pnas.78.6.3887","article-title":"Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response","volume":"78","author":"Dahlen","year":"1981","journal-title":"Proc Natl Acad Sci USA."},{"key":"B226","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.6808665","article-title":"Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction","volume":"217","author":"Michelassi","year":"1982","journal-title":"Science."},{"key":"B227","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1161\/01.CIR.97.24.2406","article-title":"Differential leukotriene constrictor responses in human atherosclerotic coronary arteries","volume":"97","author":"Allen","year":"1998","journal-title":"Circulation."},{"key":"B228","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.smim.2017.07.002","article-title":"The role of the LTB4-BLT1 axis in chemotactic gradient sensing and directed leukocyte migration","volume":"33","author":"Subramanian","year":"2017","journal-title":"Semin Immunol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1161\/01.CIR.92.11.3304","article-title":"Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells","volume":"92","author":"Datta","year":"1995","journal-title":"Circulation."},{"key":"B230","first-page":"655","article-title":"Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism","volume":"281","author":"Pedersen","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"B231","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cardiores.2007.05.018","article-title":"Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro","volume":"76","author":"Kaetsu","year":"2007","journal-title":"Cardiovasc Res."},{"key":"B232","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.105.545616","article-title":"Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment","volume":"112","author":"Heller","year":"2005","journal-title":"Circulation."},{"key":"B233","doi-asserted-by":"publisher","first-page":"17501","DOI":"10.1073\/pnas.0505845102","article-title":"Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia","volume":"102","author":"Back","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B234","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/hq0302.105593","article-title":"Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice","volume":"22","author":"Aiello","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2010.05.003","article-title":"Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice","volume":"212","author":"Choi","year":"2010","journal-title":"Atherosclerosis."},{"key":"B236","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1124\/jpet.106.110361","article-title":"Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis","volume":"320","author":"Vidal","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"B237","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/STROKEAHA.108.525733","article-title":"Genetic variation in the leukotriene pathway and carotid intima-media thickness: a 2-stage replication study","volume":"40","author":"Bevan","year":"2009","journal-title":"Stroke."},{"key":"B238","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.868934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T04:52:44Z","timestamp":1675486364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.868934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":238,"alternative-id":["10.3389\/fcvm.2022.868934"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.868934","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"article-number":"868934"}}